These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 28130335)

  • 1. Development of dilated cardiomyopathy and impaired calcium homeostasis with cardiac-specific deletion of ESRRβ.
    Rowe GC; Asimaki A; Graham EL; Martin KD; Margulies KB; Das S; Saffitz J; Arany Z
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H662-H671. PubMed ID: 28130335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.
    Jia Y; Chang HC; Schipma MJ; Liu J; Shete V; Liu N; Sato T; Thorp EB; Barger PM; Zhu YJ; Viswakarma N; Kanwar YS; Ardehali H; Thimmapaya B; Reddy JK
    PLoS One; 2016; 11(8):e0160755. PubMed ID: 27548259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial-specific ablation of
    Cho E; Kang H; Kang DK; Lee Y
    J Biol Chem; 2019 Mar; 294(13):4981-4996. PubMed ID: 30700554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence.
    Gonzalez-Valdes I; Hidalgo I; Bujarrabal A; Lara-Pezzi E; Padron-Barthe L; Garcia-Pavia P; Gómez-del Arco P; Redondo JM; Ruiz-Cabello JM; Jimenez-Borreguero LJ; Enriquez JA; de la Pompa JL; Hidalgo A; Gonzalez S
    Nat Commun; 2015 Mar; 6():6473. PubMed ID: 25751743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis.
    Zhao J; Yin M; Deng H; Jin FQ; Xu S; Lu Y; Mastrangelo MA; Luo H; Jin ZG
    Cell Death Differ; 2016 Apr; 23(4):695-706. PubMed ID: 26517531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
    Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy.
    Nakano SJ; Walker JS; Walker LA; Li X; Du Y; Miyamoto SD; Sucharov CC; Garcia AM; Mitchell MB; Ambardekar AV; Stauffer BL
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1221-H1230. PubMed ID: 31625780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil Extracellular Traps in Myocardial Tissue Drive Cardiac Dysfunction and Adverse Outcomes in Patients With Heart Failure With Dilated Cardiomyopathy.
    Ichimura S; Misaka T; Ogawara R; Tomita Y; Anzai F; Sato Y; Miura S; Yokokawa T; Sato T; Oikawa M; Kobayashi A; Yoshihisa A; Takeishi Y
    Circ Heart Fail; 2024 Jun; 17(6):e011057. PubMed ID: 38847093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of arrhythmogenic cardiomyopathy.
    McCauley MD; Wehrens XH
    Dis Model Mech; 2009; 2(11-12):563-70. PubMed ID: 19892887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure.
    Huby AC; Turdi S; James J; Towbin JA; Purevjav E
    Clin Sci (Lond); 2016 Feb; 130(4):289-99. PubMed ID: 26566650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction.
    Touvron M; Escoubet B; Mericskay M; Angelini A; Lamotte L; Santini MP; Rosenthal N; Daegelen D; Tuil D; Decaux JF
    Dis Model Mech; 2012 Jul; 5(4):481-91. PubMed ID: 22563064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-Specific Deletion of Orai3 Leads to Severe Dilated Cardiomyopathy and Heart Failure in Mice.
    Gammons J; Trebak M; Mancarella S
    J Am Heart Assoc; 2021 Apr; 10(8):e019486. PubMed ID: 33849280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis.
    Huang ZP; Kataoka M; Chen J; Wu G; Ding J; Nie M; Lin Z; Liu J; Hu X; Ma L; Zhou B; Wakimoto H; Zeng C; Kyselovic J; Deng ZL; Seidman CE; Seidman JG; Pu WT; Wang DZ
    J Clin Invest; 2015 Nov; 125(11):4122-34. PubMed ID: 26436652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced hybrid/complex N-glycosylation disrupts cardiac electrical signaling and calcium handling in a model of dilated cardiomyopathy.
    Ednie AR; Parrish AR; Sonner MJ; Bennett ES
    J Mol Cell Cardiol; 2019 Jul; 132():13-23. PubMed ID: 31071333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
    Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
    Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular Remodeling in Filamin C Deficient Mouse Hearts Impairs Myocyte Tension Development during Progression of Dilated Cardiomyopathy.
    Powers JD; Kirkland NJ; Liu C; Razu SS; Fang X; Engler AJ; Chen J; McCulloch AD
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-specific disruption of Bin1 in mice enables a model of stress- and age-associated dilated cardiomyopathy.
    Laury-Kleintop LD; Mulgrew JR; Heletz I; Nedelcoviciu RA; Chang MY; Harris DM; Koch WJ; Schneider MD; Muller AJ; Prendergast GC
    J Cell Biochem; 2015 Nov; 116(11):2541-51. PubMed ID: 25939245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure.
    Nonaka M; Morimoto S; Murayama T; Kurebayashi N; Li L; Wang YY; Arioka M; Yoshihara T; Takahashi-Yanaga F; Sasaguri T
    Br J Pharmacol; 2015 May; 172(9):2369-82. PubMed ID: 25560565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.